search for books and compare prices
Tables of Contents for Alternatives to Animals in the Development and Control of Biological Products for Human and Veterinary Use
Chapter/Section Title
Page #
Page Count
Plenary Session I
Vaccines, Animals and Man
3
16
W.M.S. Russell
Developments in the Reduction Refinement and Replacement of Animal Tests in the Quality Control of Immunobiologicals
13
6
J.G. Kreeftenberg
Session I
Current Regulations and Regulatory Policy on Alternatives
19
18
J.G. Kreeftenberg
CBER: New Approaches to Biological Product Testing
21
6
J.A. Donlon
Requirement to Consider Alternatives in the United States
27
2
R. De Haven
Alternatives to Animals in the Development and Control of Biological Products for Human and Veterinary Use. The Role of the European Pharmacopoeia
29
8
A. Artiges
Session II
Alternatives to in Vivo Immunogenicity Tests and Antibody Production
37
28
A.R. Shaw
Synthetic Peptide Vaccines: Foot-and-Mouth Disease Virus as a Model
39
6
F. Sobrino
E. Blanco
M. Garcia-Briones
V. Ley
Antibody Production Without Animals
45
4
B.M. Stadler
Use of Animal Testing for Evaluating Glycoconjugate Vaccine Immunogenicity
49
8
D.V. Madore
N. Strong
R. Eby
Membrane-based Cell Culture Systems - an Alternative to in vivo Production of Monoclonal Antibodies
57
8
A. Nagel
S. Koch
U. Valley
F. Emmrich
U. Marx
Session III
Alternatives to in Vivo Potency and Protection Tests
65
54
R. Dobbelaer
Alternatives to in Vivo Potency and Protection Tests for Veterinary Vaccines
67
6
R.N. Lucken
Viral Veterinary Vaccines
73
6
P.P. Pastoret
F. Falize
Poultry Vaccines: An Analysis of the Animal Trials Required for Vaccine Testing and the Way to Reduce or Refine these Tests
79
6
C. Jungback
B. Kuchler
E.M. Schirk
Development of Monoclonal Antibodies Suitable for Use in Antigen Quantification Potency Tests for Clostridial Veterinary Vaccines
85
10
P.J. Hauer
N.E. Clough
Development of a Nitric Oxide Induction Assay as a Potential Replacement for the Intracerebral Mouse Protection Test for Potency Assay of Pertussis Whole Cell Vaccines
95
10
C. Canthaboo
D. Xing
M. Corbel
Evaluation of Toxin Neutralisation in Test Systems for Diphtheria Antibody Assessment
105
8
J. Vandenberg
J.W. van der Gun
C.F.M. Hendriksen
Potency Testing of Anti-Lymphocyte Globulins: in Vitro Alternatives for the Monkey Skin Graft Assay
113
6
C. Conrad
O. Janssen
G. Schaffner
D. Kabelitz
Session IV
Alternatives to in Vivo Toxicity and Safety Tests
119
36
D. Sesardic
A 4R Concept for the Safety Testing of Immunobiologicals
121
6
K. Cussler
Neurovirulence
127
4
D. Wood
Detection of Endotoxins and other Pyrogens Using Human Whole Blood
131
10
S. Fennrich
M. Fischer
T. Hartung
P. Lexa
T. Montag-Lessing
H.G. Sonntag
M. Weigandt
A. Wendel
Novel Assays for the Detection of Botulinum Toxins in Foods
141
6
M. Wictome
K.A. Newton
K. Jameson
P. Dunnigan
S. Clarke
J. Gaze
A. Tauk
K.A. Foster
C.C. Shone
Toxicity Tests on Native and Recombinant Bordetella pertussis Adenylate Cyclase Toxin Preparations
147
8
K. Hormozi
R. Parton
J. Coote
Session V
Physicochemical Alternatives to Bioassays
155
30
J. van Noordwijk
Introduction
157
2
J. van Noordwijk
Hormones: The Role of the European Pharmacopoeia
159
10
E. Charton
The Development of Non-Animal Based Bioassays for Cytokines and Growth Factors
169
8
A.R. Mire-Sluis
New Methods for the Characterisation of Biopharmaceuticals: Conjugate Vaccines Against Haemophilus influenzae type b
177
8
X. Lemercinier
D. Crane
C. Gee
S. Austin
B. Bolgiano
C. Jones
Session VI
Reduction and Refinement of in Vivo Tests
185
16
C.F.M. Hendriksen
Refinement of in Vivo Tests
187
8
D.B. Morton
Reduction in Animal Use in the Production and Testing of Biologicals
195
6
M.F.W. Festing
Session VII
Validation, Acceptance and Global Harmonization of Alternative Methods
201
14
E. Griffiths
Alternatives and Developing Countries
203
6
J.B. Milstien
N. Dellepiane
The Use of Alternatives to Animal Tests in Developing Countries
209
6
H.A. Hong
J. Hendriks
Session VIII
Case Reports and Collaborative Studies
215
80
J.-M. Spieser
Validation of Test Methods in the Quality Control of Biologicals
217
6
C.F.M. Hendriksen
Use of the Single Dilution Test for the EP Tetanus Toxoid Potency Assay
223
24
B.L. McKee
Tetanus Antibodies Measured by the Toxin Binding Inhibition Test (ToBI) in Mothers and Children in the Neonatal Tetanus Program in Vietnam
247
8
N.Q. Anh
H.A. Hong
T.N. Nhon
N.D. Thinh
N.T. Van
J. Hendriks
Statistical Evaluation of Numbers of Animals to be Used in Vaccine Potency Testing: A Practical Approach
255
6
A.M. Akkermans
C.F.M. Hendriksen
Veterinary Vaccines: In-VITRO - International Veterinary Industry Test Replacement Organisation
261
6
K. Redhead
R. Lucken
A. van de Moer
S. Houghton
B. Simpson
A. Cameron
P. Monkton
K. Hennesy
C. Ellis
Validation of In Vitro Assays for Botulinum Toxin: A Case Study
267
10
R.E. Gaines Das
A.B. Heath
H. Martin
D. Sesardic
Serological Assays as Alternatives to the Ph Eur Challenge Test for Batch Release of Tetanus Vaccines for Human Use
277
12
R. Winsnes
C.F.M. Hendriksen
D. Sesardic
A. Akkermans
A. Daas
Release Potency Tests of Hepatitis Vaccines
289
6
J. Descamps
A. Mary
E. Rommel
M.L. Anhoury
R. De Neys
M. Duchene
Poster Session
Poster Presentations
295
2
Abstracts
297